These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5279993)

  • 21. Effect of the Vinca alkaloids on RNA synthesis in human cells in vitro.
    Wagner EK; Roizman B
    Science; 1968 Nov; 162(3853):569-70. PubMed ID: 5706939
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia.
    Meriwether WD; Bachur NR
    Cancer Res; 1972 Jun; 32(6):1137-42. PubMed ID: 5030814
    [No Abstract]   [Full Text] [Related]  

  • 23. L-asparaginase-induced alterations of Burkitt's lymphoma cells.
    Perez-Bercoff R; Carrara G; Cioé L; Rita G; Caputo A; Castelli L
    J Natl Cancer Inst; 1973 Apr; 50(4):833-40. PubMed ID: 4350026
    [No Abstract]   [Full Text] [Related]  

  • 24. Synchronization and recruitment in acute leukemia.
    Lampkin BC; Nagao T; Mauer AM
    J Clin Invest; 1971 Oct; 50(10):2204-14. PubMed ID: 5286686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Kinetic effect of cytostatic drugs on the generation cycle of human leukaemic blast cells in vivo. A review].
    Ernst P
    Ugeskr Laeger; 1974 Mar; 136(13):695-703. PubMed ID: 4522768
    [No Abstract]   [Full Text] [Related]  

  • 26. Serine requirement in leukemic and normal blood cells.
    Regan JD; Vodopick N; Takeda S; Lee WH; Faulcon FM
    Science; 1969 Mar; 163(3874):1452-3. PubMed ID: 5251122
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibition of f2 RNA directed E. coli protein synthesis by poly rI-rC in vitro.
    Chao J; Chao L; Speyer J
    Biochem Biophys Res Commun; 1971 Nov; 45(4):1096-102. PubMed ID: 4940604
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemotherapeutic sensitivity of acute lymphoblastic leukemia cells in culture: correlation with clinical efficacy on donor patients.
    Beranek JT; Ohnuma T; Takahashi I; Minowada J; Holland JF
    Cancer Drug Deliv; 1984; 1(4):307-19. PubMed ID: 6242352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the sensitivity to cytostatics of leukemia cells by labeling with tritiated thymidine and uridine: comparison with clinical response].
    Burgaleta C; Serrano LG; Moreno MT; Dancausa JP
    Sangre (Barc); 1985; 30(5):831-8. PubMed ID: 3867160
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of L-asparaginase on the synthesis and processing of ribosomal precursor RNA in PHA-stimulated lymphocytes.
    Torelli UL; Torelli GM; Andreoli A; Mauri C
    Experientia; 1970 Dec; 26(12):1366-8. PubMed ID: 5492228
    [No Abstract]   [Full Text] [Related]  

  • 31. Biochemical studies with 1 beta-D-arabinofuranosylcytosine in human leukemic leukocytes and normal bone marrow cells.
    Creasey WA; DeConti RC; Kaplan SR
    Cancer Res; 1968 Jun; 28(6):1074-81. PubMed ID: 5241767
    [No Abstract]   [Full Text] [Related]  

  • 32. The acute leukemic cell. V. RNA synthesis in peripheral blood and bone marrow.
    Schumacher HR; McFeely AE; Davis KD; Maugel TK
    Am J Med Sci; 1971 Dec; 262(6):327-32. PubMed ID: 5291592
    [No Abstract]   [Full Text] [Related]  

  • 33. Inhibition of DNA and RNA synthesis by daunorubicin in sensitive and resistant Ehrlich ascites tumor cells in vitro.
    Dano K; Frederiksen S; Hellung-Larsen P
    Cancer Res; 1972 Jun; 32(6):1307-14. PubMed ID: 5063994
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of deoxyribonucleic acid-reactive drugs on ribonucleic acid synthesis in leukemia L1210 cells.
    Kann HE; Kohn KW
    Mol Pharmacol; 1972 Sep; 8(5):551-60. PubMed ID: 4117298
    [No Abstract]   [Full Text] [Related]  

  • 35. Prediction of in vivo cytotoxicity of chemotherapeutic agents by their in vitro effect on leukocytes from patients with acute leukemia.
    Cline MJ; Rosenbaum E
    Cancer Res; 1968 Dec; 28(12):2516-21. PubMed ID: 5248517
    [No Abstract]   [Full Text] [Related]  

  • 36. Liposomal encapsulation of a synergistic molar ratio of cytarabine and daunorubicin enhances selective toxicity for acute myeloid leukemia progenitors as compared to analogous normal hematopoietic cells.
    Kim HP; Gerhard B; Harasym TO; Mayer LD; Hogge DE
    Exp Hematol; 2011 Jul; 39(7):741-50. PubMed ID: 21530609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The trials of determination of acute leukemia blasts sensitivity against cytostatics (author's transl)].
    Grazybek-Hryncewicz K; Biernacka I; Brzuchowska W; Kuliczkowski K; Luczkiewicz-Mulczykowa A; Kotlarek-Haus S
    Przegl Lek; 1981; 38(2):289-94. PubMed ID: 6941335
    [No Abstract]   [Full Text] [Related]  

  • 38. Antineoplastic drug activity in the mitotic cycle--effects of six agents on macromolecular synthesis in synchronous mammalian leukemic cells.
    Bosmann HB
    Biochem Pharmacol; 1972 Jul; 21(14):1977-88. PubMed ID: 4675278
    [No Abstract]   [Full Text] [Related]  

  • 39. [Round table conference--present status and the future of treatment of leukemia].
    Nihon Rinsho; 1971; 29(6):1530-50. PubMed ID: 5283279
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effects of chimiotherapy on the cellular kinetics. I. Evolution, as a function of time, of the erythroblastic proliferation. Interest of this fact for the choice of a sequential therapy].
    Najean Y
    Nouv Rev Fr Hematol; 1971; 11(2):185-202. PubMed ID: 4252672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.